Pediatric Dermatology· 2026Q2
Interim Update on Reactive Infectious Mucocutaneous Eruption ( RIME )
- 0citations
- Q2SCImago
- 2026year
Short summary
A consensus process by Pediatric Dermatology Research Alliance (PeDRA) researchers provides an interim update on the diagnosis and management of Reactive Infectious Mucocutaneous Eruption (RIME), a condition characterized by blistering skin and mucosal lesions.
AI-generated from the title and abstract; the full text is not read.
Key points
- RIME is defined by blistering skin and mucosal lesions.
- First described in 2021, RIME has a growing body of literature on its triggers, management, and complications.
- This update is an interim consensus perspective from PeDRA researchers.
- The focus is on practical information for clinicians regarding RIME diagnosis and management.
AI-generated from the title and abstract; the full text is not read.
Abstract
ABSTRACT Reactive infectious mucocutaneous eruption (RIME), a term describing blistering skin and mucosal lesions, is a term coined by a group of Pediatric Dermatology Research Alliance (PeDRA) researchers and first published in 2021. Since that time, the literature has grown with reports of diverse infectious triggers, management strategies, and complications. This expert opinion PeDRA perspective, developed by a group conducting a consensus process on management of RIME, is an interim update on the current state of diagnosis and management of RIME with a focus on practical information for the busy clinician.
The authors' abstract, as published at the source. Pediatric Dermatology, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Dermatology
DermatologyMedicine